Third, meanwhile, the benefits of angiotensin II may extend to patients with acute kidney injury or those with high-renin levels, renal outcomes of angiotensin II could not be evaluated in our review as the renal outcomes were not reported in almost all the included studies, warranting future research to address the renal outcomes of angiotensin II. This evidence concerns the gene REN and acute kidney injury.